Belpointe Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,782
Closed -$328K 915
2024
Q1
$328K Buy
+1,782
New +$339K 0.02% 556
2023
Q2
Sell
-646
Closed -$109K 2738
2023
Q1
$109K Buy
646
+138
+27% +$24.6K 0.01% 1253
2022
Q4
$86K Sell
508
-374
-42% -$67.8K 0.01% 1322
2022
Q3
$165K Sell
882
-436
-33% -$91.9K 0.01% 924
2022
Q2
$214K Buy
1,318
+609
+86% +$96.3K 0.01% 799
2022
Q1
$133K Buy
709
+251
+55% +$47.7K 0.01% 1086
2021
Q4
$121K Sell
458
-96
-17% -$25.9K 0.01% 1114
2021
Q3
$160K Buy
+554
New +$142K 0.01% 954
2021
Q1
Sell
-1,960
Closed -$376K 1059
2020
Q4
$376K Buy
+1,960
New +$357K 0.03% 481

Other funds holding RGEN

Belpointe Asset Management's RGEN Position: Q2 2024 in Review

Belpointe Asset Management sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,782 shares — an estimated $328K sold.

Belpointe Asset Management first reported a position in RGEN in Q4 2020 and held it in 9 quarters. The position peaked at $376K in Q4 2020. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Belpointe Asset Management reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Belpointe Asset Management sold 1,782 Repligen shares in Q2 2024, an estimated $328K.
  • Belpointe Asset Management first reported a position in Repligen in Q4 2020 and held it in 9 quarters.
  • Belpointe Asset Management's Repligen position peaked at $376K in Q4 2020.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Belpointe Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.